Dobutamine Stress Testing as a Diagnostic Tool for Evaluation of Myocardial Contractile Reserve in Asymptomatic or Mildly Symptomatic Patients With Dilated Cardiomyopathy
Dobutamine Stress Testing as a Diagnostic Tool for Evaluation of Myocardial Contractile Reserve in Asymptomatic or Mildly Symptomatic Patients With Dilated Cardiomyopathy
复制标题
DOI:
10.1016/j.jcmg.2008.04.012
复制
发表时间:
2008-11-01
影响因子:
14
通讯作者:
Yokota, Mitsuhiro
中科院分区:
文献类型:
--
作者:
Kobayashi, Masakazu;Izawa, Hideo;Yokota, Mitsuhiro
OBJECTIVES We performed dobutamine stress testing for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy (DCM).BACKGROUND Catecholamine sensitivity is reduced in failing hearts as a result of myocardial abnormalities in the beta-adrenergic receptor signaling pathway. However, little is known about adrenergic myocardial contractile reserve in asymptomatic or mildly symptomatic patients with DCM.METHODS The maximal first derivative of left ventricular pressure (LV dP/dt(max)) was determined during infusion of dobutamine (10 mu g kg(-1) min(-1)) in 46 asymptomatic or mildly symptomatic (New York Heart Association functional class I or II) patients with DCM. The expression of messenger ribonucleic acid (mRNA) for contractile regulatory proteins in endomyocardial biopsy specimens was quantified by reverse transcription and real-time polymerase chain reaction analysis. Plasma norepinephrine levels were measured in all patients and [I-123]metaiodobenzylguanidine (MIBG) scintigraphy performed.RESULTS Patients were classified into 3 groups based on the percentage increase in LV dP/dt(max) induced by dobutamine (Delta LV dP/dt(max)) and on LV ejection fraction (LVEF) at baseline: group I (n = 18): Delta LV dP/dt(max) > 100% and LVEF > 25%; group IIa (n = 17): Delta LV dP/dt(max) 25%; and group IIb (n = 11): Delta LV dP/dt(max)